CAPILLARY ELECTROPHORESIS FOR THE CONTROL OF THE OPTIMAL DOSE OF NTBC (2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-1,3-CYCLOHEXANEDIONE) IN SERUM SAMPLES OF HEREDITARY TYROSINEMIA TYPE I PATIENTS

被引：0
|
作者：
Cansever, M. Serif [1 ]
Zeybek, A. Cigdem Aktuglu [1 ]
Erim, F. Bedia [2 ]
机构：
[1] Univ Istanbul, Cerrahpasa Med Sch, Dept Pediat Metab Dis & Nutr, Istanbul, Turkey
[2] Istanbul Tech Univ, Dept Chem, TR-80626 Istanbul, Turkey
来源：
MOLECULAR GENETICS AND METABOLISM | 2009年 / 98卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
232
引用
收藏
页码：33 / 33
页数：1
相关论文
共 19 条
  • [1] Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione)
    Holme, E
    Lindstedt, S
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (05) : 507 - 517
  • [2] The effectiveness of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) as a therapeutic agent for tyrosinemia-I: The US experience
    Scott, CR
    Sniderman, LC
    Smith, CO
    Feldman, K
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 168A - 168A
  • [3] Extensive changes in liver gene expression induced by hereditary tyrosinemia type I are not normalized by treatment with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC)
    Luijerink, MC
    Jacobs, SMM
    van Beurden, EACM
    Koornneef, LP
    Klomp, LWJ
    Berger, R
    van den Berg, IET
    [J]. JOURNAL OF HEPATOLOGY, 2003, 39 (06) : 901 - 909
  • [4] Liquid chromatography tandem mass spectrometry method for the quantitation of NTBC (2-(nitro-4-trifluoromethylbenzoyl)1,3-cyclohexanedione) in plasma of tyrosinemia type 1 patients
    Herebian, Diran
    Spiekerkoetter, Ute
    Lamshoeft, Marc
    Thimm, Eva
    Laryea, Maurice
    Mayatepek, Ertan
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2009, 877 (14-15): : 1453 - 1459
  • [5] Clinical follow up of Chilean patients with tyrosinemia type 1 treated with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-ciclohexanedione (NTBC)
    Raimann, Erna
    Cornejo, Veronica
    Arias, Carolina
    Francisco Cabello, Juan
    Castro, Gabriela
    Fernandez, Eloina
    de la Parra, Alicia
    [J]. REVISTA MEDICA DE CHILE, 2012, 140 (02) : 169 - 175
  • [6] From toxicological problem to therapeutic use: The discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug
    Lock, EA
    Ellis, MK
    Gaskin, P
    Robinson, M
    Auton, TR
    Provan, WM
    Smith, LL
    Prisbylla, MP
    Mutter, LC
    Lee, DL
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (05) : 498 - 506
  • [7] Characterization of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione resistance in pyomelanogenic Pseudomonas aeruginosa DKN343
    Ketelboeter, Laura M.
    Bardy, Sonia L.
    [J]. PLOS ONE, 2017, 12 (06):
  • [8] Determination of NTBC in serum samples from patients with hereditary tyrosinemia type I by capillary electrophoresis
    Cansever, M. Serif
    Aktuglu-Zeybek, A. Cigdem
    Erim, F. Bedia
    [J]. TALANTA, 2010, 80 (05) : 1846 - 1848
  • [9] Determination of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in plasma by direct injection into a coupled column liquid chromatographic system
    Bielenstein, M
    Astner, L
    Ekberg, S
    [J]. JOURNAL OF CHROMATOGRAPHY B, 1999, 730 (02): : 177 - 182
  • [10] Hepatocellular carcinoma in hereditary tyrosinemia type I despite 2-(2 nitro-4-3 trifluoro-methylbenzoyl)-1,3-cyclohexanedione treatment
    van Spronsen, FJ
    Bijleveld, CMA
    van Maldegem, TT
    Wijburg, FA
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2005, 40 (01): : 90 - 93
12